Akari Therapeutics Appoints Industry Veteran Wa’el Hashad to Board of Directors

2 years ago

NEW YORK and LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing…

Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets

2 years ago

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic…

Talis Biomedical Announces 1-for-15 Reverse Stock Split

2 years ago

REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing…

MIMEDX Appoints Doug Rice as Chief Financial Officer

2 years ago

Company adds seasoned MedTech CFO to leadership teamMARIETTA, Ga., July 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG)…

Positive Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder

2 years ago

Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the…

Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer

2 years ago

Oak Ridge, TN, July 05, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement…

Ayala Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA Regarding AL102 for the Treatment of Desmoid Tumors

2 years ago

Company confirms FDA agreement on key elements of the Phase 3 segment of ongoing RINGSIDE study, including dosing regimen of…

Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites

2 years ago

University of Alabama enrolls patient 65 after second day of opening for enrollmentTORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Spectral…

Cortexa Makes First Drug Order for Australian Commercial Market

2 years ago

PharmAla’s Australian Joint Venture Orders First Shipment of MDMA and Psilocybin for Commercial UseVANCOUVER, British Columbia, July 04, 2023 (GLOBE…